StonvexLoading…
StonvexStonvexStonvexCore line items from JVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $96.28M | $78.56M | $68.17M | $65.71M |
Operating Income | $2.15M | $2.96M | $-1.33M | $-5.34M |
Net Income | $1.40M | $2.22M | $-835.58K | $-3.74M |
EPS (Diluted) | $0.25 | $0.39 | $-0.15 | $-0.66 |
Total Assets | $42.05M | $34.01M | $42.19M | $42.69M |
Total Liabilities | $14.47M | $7.83M | $18.48M | $18.14M |
Cash & Equivalents | $701.87K | $1.38M | $2.73M | $2.52M |
Free Cash Flow OCF − CapEx | $-5.21M | $5.12M | $-205.68K | $-6.50M |
Shares Outstanding | 5.71M | 5.71M | 5.71M | 5.71M |